Report Summary

The global allergy diagnostics market size was estimated at USD 3.0 billion in 2017 and is anticipated to gain significant traction over coming years.

An allergy is a hypersensitivity disease of the body immune system. Allergic arises when an individual’s immune system reacts to any harmless substances known as allergens. There is a number of factors that cause allergy by affecting the immune system. Some of the general factors include pet dander, pollen, and dust mite excretion. There are several kinds of allergies such as drug allergy, dust allergy, skin allergy, food allergy, mold allergy and allergy to insect stings. Drug allergy is initiated due to the allergic response to certain components in drugs. This type of allergy can trigger indications such as facial swelling, hives, itchy eyes, and skin rash. Dust allergy is caused by pollen, dust mites, pet hair, and mold. Dust allergy can generate asthma symptoms. Skin allergy may arise due to, immune system disorders, medication, and infections, and skin infection triggers indications such as itchy, red, bumpy, scaly and swollen skin. Food allergy is usually caused by the intake of certain proteins found in the diet and can generate symptoms such as rashes and gastric complications. Mold allergy is caused by the microorganisms and small fungi floating through the air. Sneezing problems are generally due to mold allergy. Allergy to insect stings can cause aching, redness, and swelling, at the site of the insect sting.

In general, a person develops allergies at any age, though, children and adolescents are highly prone to allergic ailments. Allergy can be treated by proper diagnostics and treatments. Allergy diagnostics denotes to defining the nature of the allergic disorder and providing on its significant course of treatment. Major tests used for the diagnosis of allergies are skin prick, intradermal, blood, and patch tests.

The global allergy diagnostics market growth is majorly driven by the high prevalence of allergic ailments such as asthma, food allergy, allergic rhinitis, sinusitis, and other respiratory allergies. Allergies are the 6th leading cause of chronic illness in the U.S. For a case, according to the Asthma and Allergy Foundation of America, approximately More than 50 million Americans have experienced various types of allergies each year. Moreover, according to the same reports, globally around 15% of the population are affected by allergic rhinitis. Growing prevalence of allergies among the global population is anticipated to drive the growth of the global market significantly. Moreover, growing government support and initiatives for development of diagnosis, novel therapies, and vaccines along with high R&D inventiveness for expansion of advanced diagnostic and treatment techniques are expected to fuel the growth of this market in the forecast period. Advancement in technology in the field of in-vitro diagnostics and growing focus on the retentive superior quality of life are some of the aspects that are expected to contribute towards the growth of global market over the forecast period. However, high cost for allergy tests and unobtainability of the tests kits are the factors that are expected to hinder the market growth.

Segment Analysis

The global Allergy Diagnostics Market Size is segmented on the basis of products, allergens, tests, end users, and geography.

On the basis of products, the global Market Share is segmented into Assay Kits, Instruments, and Consumables. Consumables segment dominated the overall industry in 2017 in as it is an essential component of allergy detection. Advancement in technology for allergen microarray kits and ELISA kits, which are more sensitive and bids adapted patient profiling & monitoring. On the basis of allergen, the global market is segmented into Food, Inhaled, Drug. In 2017, the inhaled segment is anticipated to dominate the global market. The major market share is due to, the increasing demand for allergy diagnosis and the introduction of specific allergen for the detection of allergy. On the basis of the test, the global market is segmented into in vitro and in vivo tests. Due to linked benefits such as wider availability and sensitivity, time efficiency, and ease of use for clinically valid allergies, in vivo segment is estimated to dominate the market. In vitro test segment is predicted to grow significantly in forecast period majorly due to growing demand for increasing lab automation and a reduced amount of invasive diagnostic methods coupled with highly sensitive & accurate results. On the basis of the end user, the global allergy diagnostics market is segmented into Hospital and Diagnostic Laboratory. In 2017, diagnostics market is estimated to dominate the global market. In addition, developments in screening methods enabling precise disease diagnosis suggesting appropriate treatment is anticipated to propel the growth opportunities for this segment.

Regional Analysis

In terms of geography, North America is estimated to dominated the allergy diagnostics market. The high occurrence of allergic ailments, rising awareness demanding proper allergy diagnostics and increasing acceptance of in vitro blood tests are attributing to the largest market share in North America. However, Asia-Pacific, on the other hand, is anticipated to dominate the global market shares in the forecast period. This is majorly due to the existence of high clinical unmet needs, developing healthcare organization and rising demand for minimally invasive diagnostic procedures.

Competitive Landscape

Major firms are focusing on small firms with a working methodology of securing the end goal to manage position in the market and are associated with mergers and acquisitions, key joint efforts, and novel item advancement to pick up profit share in the business. Some major key players in global Allergy Diagnostics Market includes bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group and Alcon Laboratories among others.